Trade Summary

3 days ago, Pakola Steve, serving as Chief Medical Officer at Regenxbio Inc. (RGNX), sold 15,309 shares at $11.02 per share, for a total transaction value of $168,705.00. Following this transaction, Pakola Steve now holds 232,617 shares of RGNX.

This sale represents a 6.00% decrease in Pakola Steve's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, May 11, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, May 13, 2026, 2 days after the trade was made.

Regenxbio Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.